Hong Hao, Li Yu-Meng, Meng Xiang-Min, Deng Tian, Zhu Bing-Mei
Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Sheng Li Xue Bao. 2022 Jun 25;74(3):461-468.
Histone methylation is one of the key post-translational modifications that plays a critical role in various heart diseases, including diabetic cardiomyopathy. A great deal of evidence has shown that histone methylation is closely related to hyperglycemia, insulin resistance, lipid and advanced glycation end products deposition, inflammatory and oxidative stress, endoplasmic reticulum stress and cell apoptosis, and these pathological factors play an important role in the pathogenesis of diabetic cardiomyopathy. In order to provide a novel theoretical basis and potential targets for the treatment of diabetic cardiomyopathy from the perspective of epigenetics, this review discussed and elucidated the association between histone methylation and the pathogenesis of diabetic cardiomyopathy in details.
组蛋白甲基化是关键的翻译后修饰之一,在包括糖尿病心肌病在内的各种心脏疾病中起关键作用。大量证据表明,组蛋白甲基化与高血糖、胰岛素抵抗、脂质及晚期糖基化终产物沉积、炎症和氧化应激、内质网应激及细胞凋亡密切相关,而这些病理因素在糖尿病心肌病的发病机制中起重要作用。为了从表观遗传学角度为糖尿病心肌病的治疗提供新的理论基础和潜在靶点,本综述详细讨论并阐明了组蛋白甲基化与糖尿病心肌病发病机制之间的关联。